While the impact of the IRA on the pharmaceutical industry cannot yet be fully determined, it is likely to be significant.
All entries for: Corvus Pharmaceuticals
May 8, 2025
Corvus Pharmaceuticals
Neutral Outlook
Burlingame, CA
51-200 employees
Disease Area: Dermatology, Immune Diseases, Multiple, Oncology
Drug Type: Biologic, Small Molecule